Campus Alert: Find the latest UMMS campus news and resources at

Search Close Search
Page Menu

William D Thomas

UMassMed Faculty Page


Title: Broadly Borreliacidal Human Monoclonal Antibodies to OspA and their Uses. UMMS15-03; Patent Pending. 

Title: Human Antibodies Against Rabies and Uses Thereof. UMMS14-48; Patent Pending. 

  • New neutralizing monoclonal antibodies for rabies RAB2 and RAB3. Can be used together or in combination with RAB1, these antibodies have demonstrated superior performance in the treatment of rabies in comparison to other individually tested antibodies and will cover variety of zootonic strains. 


Innovation TopicsBiologicsInfectious DiseaseBorreliaBorreliacidal/lymeHuman monoclonalAntibodyPost-exposure prophylacticRabies